In a recent study published in the journal Food Science & Nutrition, researchers investigated creatine supplementations as a potential intervention strategy to attenuate the clinical symptoms of post-COVID-19 fatigue syndrome.
Risk Adjusted Net Present Value: What is the current valuation of Vor BioPharma’s Tremtelectogene Empogeditemcel
The revenue for Tremtelectogene Empogeditemcel is expected to reach an annual total of $91 mn by 2039 globally based off GlobalData’s Expiry Model. The drug’s
August 28, 2023